Who Paid My Doc
John Petersen
Cardiovascular Disease Seattle, WA Medical Doctor
NPI 1306926225 CMS profile 104231
801 Broadway Ste 808, Seattle, WA 98122
General payments
$5,801
Research payments
$0
Ownership & investment interest
$0
Research they led as principal investigator
$302,709
Through program year 2024, John Petersen of Seattle, WA is reported in the CMS Open Payments database as having received $5,801 across 23 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $302,709 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 72nd percentile of Cardiovascular Disease profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
5 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $216 | 3 | |
| 2023 | General | $343 | 4 | |
| 2022 | General | $2,706 | 2 | |
| 2021 | General | $1,683 | 2 | |
| 2019 | General | $853 | 12 |
Beside peers
- John Petersen
- Cardiovascular Disease median
- Middle half of Cardiovascular Disease
- National median
In program year 2025, general payments to John Petersen were reported at $0. Among 16,617 Cardiovascular Disease profiles paid that year, the median was $432 and the middle half received between $132 and $1,252.
Show as a table
| Year | John Petersen | Cardiovascular Disease median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $853 | $450 | $127–$1,392 | $163 |
| 2020 | $0 | $242 | $77–$751 | $114 |
| 2021 | $1,683 | $335 | $101–$1,037 | $132 |
| 2022 | $2,706 | $395 | $121–$1,211 | $149 |
| 2023 | $343 | $443 | $136–$1,283 | $160 |
| 2024 | $216 | $450 | $136–$1,323 | $164 |
| 2025 | $0 | $432 | $132–$1,252 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Cardiovascular Disease in Washington
Robert Bersin
Cardiovascular Disease · Bellevue, WA
Mariko Harper
Cardiovascular Disease · Seattle, WA
Gary Oppenheim
Cardiovascular Disease · Seattle, WA
Kelley Branch
Cardiovascular Disease · Seattle, WA
Munish Kumar Kannabhiran
Cardiovascular Disease · Richland, WA
Erik Wissner
Cardiovascular Disease · Seattle, WA
Related records
Cardiovascular Disease in Washington
Practitioners in the same specialty and state, ranked by reported value.
All Cardiovascular Disease
Everyone recorded under this specialty, nationwide.
Doctors in Washington
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.